Literature DB >> 33409928

Longitudinal Assessment of Prevalence and Risk Factors of Anxiety and Depression among Prostate Cancer Survivors Post-Resection.

Ruibin Yu1, Haibo Li2.   

Abstract

Our study aimed to detect the longitudinal prevalence of anxiety and depression in prostate cancer survivors post-resection and their risk factors. A total of 169 prostate cancer patients who underwent resection were included and followed up for 3 years. Then anxiety and depression were assessed by Zung's Self-rating Anxiety Scale (SAS) or Zung's Self-rating Depression Scale (SDS) from the day of discharging from hospital to the last follow up every 3 months. Overall survival (OS) was calculated and documented. In prostate cancer survivors post-resection, the SAS score, anxiety occurrence rate, SDS score and depression occurrence rate all gradually elevated from baseline to month 36. Multivariate logistic regression analysis disclosed that age ≥ 65 years, education duration<9 years, marry status of single/divorced/widowed, unemployment before surgery, diabetes, and hyperlipidemia, higher Gleason score, higher pathological T stage, higher pathological N stage, positive surgical margin status were independent factors related to higher anxiety risk in the 3 years follow-up duration. Additionally, unemployment before surgery, hyperlipidemia, higher pathological T stage, higher pathological N stage, positive surgical margin status were independently associated with depression risk in the 3 years follow-up duration. In addition, baseline anxiety, baseline depression, 1-year depression and 2-year depression associated with worse OS. In conclusion, post-resection anxiety and depression continuously worsen in prostate cancer survivors, and age, marriage status, education duration, complications, and tumor features can serve as their risk factors.

Entities:  

Keywords:  Anxiety; Depression; Prevalence; Prostate cancer survivor; Risk factors

Year:  2021        PMID: 33409928     DOI: 10.1007/s11126-020-09869-5

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  25 in total

Review 1.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

2.  Prostate cancer-specific anxiety and the resulting health-related quality of life in couples.

Authors:  Ching-Hui Chien; Cheng-Keng Chuang; Kuan-Lin Liu; See-Tong Pang; Chun-Te Wu; Ying-Hsu Chang
Journal:  J Adv Nurs       Date:  2018-09-17       Impact factor: 3.187

Review 3.  Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.

Authors:  Michael Lardas; Matthew Liew; Roderick C van den Bergh; Maria De Santis; Joaquim Bellmunt; Thomas Van den Broeck; Philip Cornford; Marcus G Cumberbatch; Nicola Fossati; Tobias Gross; Ann M Henry; Michel Bolla; Erik Briers; Steven Joniau; Thomas B Lam; Malcolm D Mason; Nicolas Mottet; Henk G van der Poel; Olivier Rouvière; Ivo G Schoots; Thomas Wiegel; Peter-Paul M Willemse; Cathy Yuhong Yuan; Liam Bourke
Journal:  Eur Urol       Date:  2017-07-27       Impact factor: 20.096

4.  Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.

Authors:  Yan Cheng; Xing-Hua Gao; Xian-Jing Li; Qiu-Hua Cao; Dan-Dan Zhao; Jin-Rong Zhou; Hong-Xi Wu; Yun Wang; Lin-Jun You; Hong-Bao Yang; Yun-Long He; Yong-Ren Li; Jin-Song Bian; Qing-Yi Zhu; Lutz Birnbaumer; Yong Yang
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

5.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.

Authors:  Alex J Mitchell; Melissa Chan; Henna Bhatti; Marie Halton; Luigi Grassi; Christoffer Johansen; Nicholas Meader
Journal:  Lancet Oncol       Date:  2011-01-19       Impact factor: 41.316

6.  Anxiety and Depression Disorders in Relation to the Quality of Life of Breast Cancer Patients with Locally Advanced or Disseminated Stage.

Authors:  Martha Carolina Valderrama Rios; Ricardo Sánchez Pedraza
Journal:  Rev Colomb Psiquiatr (Engl Ed)       Date:  2017-05-31

Review 7.  Anxiety.

Authors:  Michelle G Craske; Murray B Stein
Journal:  Lancet       Date:  2016-06-24       Impact factor: 79.321

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 9.  The Diagnosis and Treatment of Prostate Cancer: A Review.

Authors:  Mark S Litwin; Hung-Jui Tan
Journal:  JAMA       Date:  2017-06-27       Impact factor: 56.272

10.  Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors.

Authors:  Suzanne Hughes; Sam Egger; Chelsea Carle; David P Smith; Suzanne Chambers; Clare Kahn; Cristina M Caperchione; Annette Moxey; Dianne L O'Connell
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

View more
  2 in total

1.  Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up.

Authors:  Vítor Duarte; Natália Araújo; Catarina Lopes; Adriana Costa; Augusto Ferreira; Filipa Carneiro; Jorge Oliveira; Isaac Braga; Samantha Morais; Luís Pacheco-Figueiredo; Luis Ruano; Vítor Tedim Cruz; Susana Pereira; Nuno Lunet
Journal:  Int J Environ Res Public Health       Date:  2022-07-26       Impact factor: 4.614

2.  Anxiety and depression in recurrent gastric cancer: Their prevalence and independent risk factors analyses.

Authors:  Lisha Zhang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.